Ethical Approval Ethical approval was not sought for the present study because did not involve consent or involvement of human participants or animal research
A study frequently mentioned in our studies [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] was a multicenter, randomized, double-blind, placebo-controlled study [257], which was performed to assess the efficacy, safety, and pharmacokinetics of BPC 157 in patients with mild to moderate ulcerative colitis
In the SURMOUNT5 trial, participants lost an average of 20.2 % of their baseline body weight over 72 weeks with tirzepatide, with a greater proportion achieving weight-loss thresholds of 1525 % compared with semaglutide
Structural insights into polysaccharides in Ganoderma lucidum cell walls by solid-state NMR